Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.This is an entirely free service. No payments are to be made.
Here is the latest stock price and chart of Aurobindo Pharma. For more details, see the Aurobindo Pharma company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
|Live BSE Quotes||Apr 27, 2017 03:33:00 PM|
|Price (Rs)606.60||Open (Rs) 625.05||High (Rs) 629.75||Low (Rs) 606.00|
|% Change-2.91||Volume 205,977||Value (Rs) 124,945,648||52-Week H/L 895.00 / 619.00|
|Live NSE Quotes||Apr 27, 2017 3:29:59 PM|
|Price (Rs)605.55||Open (Rs) 624.65||High (Rs) 629.75||Low (Rs) 605.00|
|% Change-3.06||Volume 2,647,133||Value (Rs) 1,627,377,954||52-Week H/L 895.00 / 618.45|
|EPS (Rs)* 39.65||P/E Ratio (x) 15.30||Market Cap (Rs m) 354,963.52||P/BV (x) 5.03|
|*Trailing 12 months earnings, excluding extraordinary / exceptional items.||BSE Sensex | CNX Nifty|
|Aurobindo Pharma Share Price Chart (Rs) - 1 Year|
Quote & Graph
S&P BSE SENSEX
Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the metal sector and FMCG sector witnessing maximum selling pressure.
Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.
Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.
Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.
Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.
Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.More Views on News
Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.
Why HDFC Bank beat the Sensex by nearly 3 times.
An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.
While it is important to get Mallya back to India, the government needs to show the same vigour in chasing defaulters of public sector bank loans residing in India.
PersonalFN explains how GST would impact India's mutual fund industry and investorsMore